Found: 17
Select item for more details and to access through your institution.
A Very Rare Cause of Bicytopenia; The Use of Vitex Acnu Castus.
- Published in:
- Academic Journal of Health, 2023, v. 1, n. 4, p. 125, doi. 10.14744/ajh.2023.76486
- By:
- Publication type:
- Article
Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 725, doi. 10.1177/10781552211060730
- By:
- Publication type:
- Article
Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2027, doi. 10.1177/10781552211007889
- By:
- Publication type:
- Article
Ibrutinib-induced polyneuropathy: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1501, doi. 10.1177/1078155220903357
- By:
- Publication type:
- Article
Mean platelet volume and platelet distribution width in the prediction of treatment response in immune thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a multicenter study.
- Published in:
- Gulhane Medical Journal, 2024, v. 66, n. 1, p. 43, doi. 10.4274/gulhane.galenos.2023.85520
- By:
- Publication type:
- Article
Analysis of demographic and clinical characteristics of primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis patients.
- Published in:
- Gulhane Medical Journal, 2021, v. 63, n. 2, p. 117, doi. 10.4274/gulhane.galenos.2020.1243
- By:
- Publication type:
- Article
Effect of Blood Groups on Clinical Presentations and Treatment Outcomes in Immune Thrombotic Thrombocytopenic Purpura Patients with Severe ADAMTS13 Deficiency: A Multi-Center Experience.
- Published in:
- Transfusion Medicine & Hemotherapy, 2023, v. 50, n. 1, p. 18, doi. 10.1159/000524597
- By:
- Publication type:
- Article
Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 4, p. 544, doi. 10.1111/jcpt.13512
- By:
- Publication type:
- Article
A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera.
- Published in:
- Istanbul Medical Journal, 2023, v. 24, n. 2, p. 120, doi. 10.4274/imj.galenos.2023.66742
- By:
- Publication type:
- Article
A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura.
- Published in:
- Case Reports in Oncology, 2020, v. 13, n. 3, p. 1368, doi. 10.1159/000510745
- By:
- Publication type:
- Article
The Relationship Between GLIM Criteria and Recovery Times in the Leukemia Treatment Process.
- Published in:
- UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi, 2023, v. 33, n. 3, p. 121, doi. 10.4999/uhod.237189
- By:
- Publication type:
- Article
The Prognostic Significance of Prognostic Nutritional Index in Diffuse Large B Cell Lymphoma Patients.
- Published in:
- UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi, 2023, v. 33, n. 1, p. 8, doi. 10.4999/uhod.236929
- By:
- Publication type:
- Article
The Charlson Comorbidity Index Predicts Poor Prognosis in Elderly AML Patients.
- Published in:
- UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi, 2023, v. 33, n. 1, p. 1, doi. 10.4999/uhod.236829
- By:
- Publication type:
- Article
Therapeutic Plasma Exchange in Neurological Disorders: A 9-year Experience.
- Published in:
- UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi, 2022, v. 32, n. 4, p. 202, doi. 10.4999/uhod.226481
- By:
- Publication type:
- Article
The Importance of Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia.
- Published in:
- UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi, 2021, v. 31, n. 4, p. 199, doi. 10.4999/uhod.215209
- By:
- Publication type:
- Article
Does Systemic Immun Inflammation Index Predict Survival in Diffuse Large B Cell Lymphoma Patients?
- Published in:
- Hitit Medical Journal, 2023, v. 5, n. 3, p. 170, doi. 10.52827/hititmedj.1301431
- By:
- Publication type:
- Article
The Impact of Hematological Parameters on Survival for Patients with COVID-19.
- Published in:
- Ahi Evran Medical Journal, 2022, v. 6, n. 3, p. 226, doi. 10.46332/aemj.1014259
- By:
- Publication type:
- Article